Patient Reported Outcomes over Time in 25,988 Axial Spondyloarthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Clinical Practice - Is PRO Remission Achieved? Results from the EuroSpA Collaboration

被引：0

作者：

Ornbjerg, Lykke Midtboll ^{[1
,2
]}

Askling, Johan ^{[3
]}

Loft, Anne Gitte ^{[4
]}

Nissen, Michael J. ^{[5
]}

Mann, Herman ^{[6
]}

Direskeneli, Haner ^{[7
,8
]}

Iannone, Florenzo ^{[9
]}

Sexton, Joe ^{[10
]}

Nordstrom, Dan ^{[11
,12
]}

Santos, Maria Jose ^{[13
]}

Codreanu, Catalin ^{[14
]}

Pombo-Suarez, Manuel ^{[15
]}

Rotar, Ziga ^{[16
]}

Gudbjornsson, Bjorn ^{[17
]}

Van der Horst-Bruinsma, Irene ^{[18
]}

Lindstrom, Ulf ^{[19
]}

Ciurea, Adrian ^{[20
]}

Pavelka, Karel ^{[6
]}

Yilmaz, Neslihan ^{[7
,21
]}

Gremese, Elisa ^{[22
]}

Kristianslund, Eirik ^{[23
]}

Hokkanen, Anna Mari ^{[24
]}

Barcelos, Anabela ^{[25
]}

Ionescu, Ruxandra ^{[26
]}

Sanchez-Piedra, Carlos ^{[27
]}

Tomsic, Matija ^{[28
]}

Geirsson, Arni Jon ^{[29
,30
]}

van de Sande, Marleen ^{[18
]}

Macfarlane, Gary ^{[31
]}

Brahe, Cecilie Heegaard ^{[32
]}

Hetland, Merete Lund ^{[1
,2
]}

Ostergaard, Mikkel ^{[33
]}

机构：

[1] Rigshosp, DANBIO, Copenhagen, Denmark

[2] Rigshosp, Ctr Head & Orthopaed, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res COPECARE, Copenhagen, Denmark

[3] Karolinska Inst, Stockholm, Sweden

[4] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark

[5] Univ Hosp Geneva, Geneva, Switzerland

[6] Inst Rheumatol, Dept Rheumatol, Fac Med 1, Prague 2, Czech Republic

[7] TURKBIO Registry, Istanbul, Turkey

[8] Marmara Univ, Sch Med, Div Rheumatol, Istanbul, Turkey

[9] Univ Hosp Bari, Rheumatol Unit, Dept Emergency & Transplantat, Bari, Italy

[10] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway

[11] Helsinki Univ Hosp, ROB FIN, Dept Med, Helsinki, Finland

[12] Univ Helsinki, Helsinki, Finland

[13] Hosp Garcia Orta, Dept Rheumatol, Almada, Portugal

[14] Univ Med & Pharm, Ctr Rheumat Dis, Bucharest, Romania

[15] Spanish Soc Rheumatol, Unit Res, Madrid, Spain

[16] UMC LJUBLJANA, DPT RHEUMATOL, Ljubljana, Slovenia

[17] Univ Iceland, Landspitali & Fac Med, Ctr Rheumatol Res, Reykjavik, Iceland

[18] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[19] Univ Gothenburg, Gothenburg, Sweden

[20] Univ Hosp Zurich, Zurich, Switzerland

[21] Bilim Univ, Sch Med, Div Rheumatol, Istanbul, Turkey

[22] Univ Cattolica Sacro Cuore, Fdn Policlin Gemelli, Rome, Italy

[23] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway

[24] Helsinki Univ Hosp, Helsinki, Finland

[25] Univ Aveiro, IBemed, Ctr Hosp Baixo Vouga, Aveiro, Portugal

[26] SPITALUL CLINIC SFANTA MARIA, Bucharest, Romania

[27] Spanish Soc Rheumatol, Res Unit, Madrid, Spain

[28] Univ Med Ctr, Dept Rheumatol, Ljubljana, Slovenia

[29] Univ Hosp, Ctr Rheumatol Res, Reykjavik, Iceland

[30] Fac Med, Reykjavik, Iceland

[31] Univ Aberdeen, Aberdeen, Scotland

[32] Rigshosp, Ctr Rheumatol & Spine Dis, Copenhagen Ctr Arthrit Res, Copenhagen, Denmark

[33] Univ Copenhagen, Copenhagen Ctr Arthrit Res, Copenhagen, Denmark

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1083

引用

页数：5

共 6 条

[1] Patient Reported Outcomes over 2 Years in Psoriatic Arthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Routine Care - Was PRO Remission Achieved? Results from the EuroSpA Collaboration
Ornbjerg, Lykke Midtboll
Jacobsson, Lennart
Loft, Anne Gitte
Iannone, Florenzo
Nissen, Michael J.
Kristianslund, Eirik
Mann, Herman
Santos, Maria Jose
Pombo-Suarez, Manuel
Eklund, Kari K.
Rotar, Ziga
Gudbjornsson, Bjorn
Ozturk, Mehmet Akif
Codreanu, Catalin
Van de Sande, Marleen
Wallman, Johan
Favalli, Ennio Giulio
Moeller, Burkhard
Sexton, Joe
Pavelka, Karel
Vieira-Sousa, Elsa
Sanchez-Piedra, Carlos
Trokovic, Nina
Tomsic, Matija
Love, Thorvardur J.
Cefle, Ayse
Ionescu, Ruxandra
Van der Horst-Bruinsma, Irene
Jones, Gareth
Brahe, Cecilie Heegaard
Hetland, Merete Lund
Ostergaard, Mikkel
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[2] DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS DEPEND ON THE REASON FROM WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION
Ornbjerg, Lykke
Brahe, Cecilie Heegaard
Loft, Anne Gitte
Askling, Johan
Ciurea, Adrian
Mann, Herman
Akar, Servet
Kristianslund, Eirik
Nordstrom, Dan
Santos, Maria Jose
Codreanu, Catalin
Pombo-Suarez, Manuel
Rotar, Ziga
Gudbjornsson, Bjorn
Di Giuseppe, Daniela
Nissen, Michael
Pavelka, Karel
Senel, Soner
Sexton, Joe
Eklund, Kari
Barcelos, Anabela
Ionescu, Ruxandra
Sanchez-Piedra, Carlos
Tomsic, Matija
Geirsson, Arni Jon
van der Horst-Bruinsma, Irene
Macfarlane, Gary
Iannone, Florenzo
Michelsen, Brigitte
Hyldstrup, Lise
Krogh, Niels Steen
Hetland, Merete L.
Ostergaard, Mikkel
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 872 - 873
[3] Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? - Real World Data from 12 European Countries in the EuroSpA Research Collaboration
Ornbjerg, Lykke Midtboll
Brahe, Cecilie Heegaard
Loft, Anne Gitte
Askling, Johan
Ciurea, Adrian
Mann, Herman
Akar, Servet
Kristianslund, Eirik
Nordstrom, Dan
Santos, Maria Jose
Codreanu, Catalin
Pombo-Suarez, Manuel
Rotar, Ziga
Gudbjornsson, Bjorn
DiGuiseppe, Daniela
Nissen, Michael J.
Pavelka, Karel
Senel, Soner
Sexton, Joe
Eklund, Kari K.
Barcelos, Anabela
Ionescu, Ruxandra
Sanchez-Piedra, Carlos
Tomsic, Matija
Geirsson, Arni Jon
van der Horst-Bruinsma, Irene
Macfarlane, Gary
Iannone, Florenzo
Michelsen, Brigitte
Hyldstrup, Lise
Krogh, Niels Steen
Hetland, Merete Lund
Ostergaard, Mikkel
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[4] DOES DRUG EFFECTIVENESS OF 2ND AND 3RD TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS DEPEND ON THE REASON FOR WITHDRAWAL FROM THE PREVIOUS TREATMENT? - RESULTS FROM THE EUROSPA RESEARCH COLLABORATION
Brahe, Cecilie Heegaard
Ornbjerg, Lykke
Jacobsson, Lennart T. H.
Nissen, Michael
Kristianslund, Eirik
Mann, Herman
Santos, Maria Jose
Pombo-Suarez, Manuel
Nordstrom, Dan
Rotar, Ziga
Gudbjornsson, Bjorn
Dalkilic, Ediz
Codreanu, Catalin
Loft, Anne Gitte
Lindstrom, Ulf
Moeller, Burkhard
Sexton, Joe
Pavelka, Karel
Barcelos, Anabela
Sanchez-Piedra, Carlos
Eklund, Kari
Tomsic, Matija
Love, Thorvardur Jon
Sari, Ismail
Ionescu, Ruxandra
van de Sande, Marleen
van der Horst-Bruinsma, Irene
Jones, Gareth T.
Iannone, Florenzo
Michelsen, Brigitte
Hyldstrup, Lise
Krogh, Niels Steen
Stergaard, Mikkel
Hetland, Merete L.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1401 - 1402
[5] Does Drug Effectiveness of 2nd and 3rd TNF Inhibitors in Patients with Psoriatic Arthritis Depend on the Reason for Withdrawal from the Previous Treatment? - Results from the EuroSpA Research Collaboration
Brahe, Cecilie Heegaard
Ornbjerg, Lykke Midtboll
Jacobsson, Lennart
Nissen, Michael J.
Kristianslund, Eirik
Mann, Herman
Santos, Maria Jose
Pombo-Suarez, Manuel
Nordstrom, Dan
Rotar, Ziga
Gudbjornsson, Bjorn
Onen, Fatos
Codreanu, Catalin
Loft, Anne Gitte
Lindstrom, Ulf
Moeller, Burkhard
Sexton, Joe
Pavelka, Karel
Barcelos, Anabela
Sanchez-Piedra, Carlos
Eklund, Kari K.
Tomsic, Matija
Love, Thorvardur J.
Can, Gercek
Ionescu, Ruxandra
van de Sande, Marleen
van der Horst-Bruinsma, Irene
Jones, Gareth
Iannone, Florenzo
Michelsen, Brigitte
Hyldstrup, Lise
Krogh, Niels Steen
Ostergaard, Mikkel
Hetland, Merete Lund
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[6] Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1st, 2nd or 3rd Line Therapy: RealWorld Results from the National Myeloma Canada Research Network (MCRN) Database
Reece, Donna E.
Masih-Khan, Esther
Atenafu, Eshetu G.
Jimenez-Zepeda, Victor
McCurdy, Arleigh
Song, Kevin
Leblanc, Richard
Sebag, Michael
White, Darrell J.
Cherniawsky, Hannah
Reiman, Tony
Stakiw, Julie
Louzada, Martha L.
Kotb, Rami
Aslam, Muhammad
Gul, Engin
Venner, Christopher P.
[J]. BLOOD, 2019, 134

← 1 →